These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

424 related articles for article (PubMed ID: 18496143)

  • 1. Immunohistochemical markers to distinguish between hemangioblastoma and metastatic clear-cell renal cell carcinoma in the brain: utility of aquaporin1 combined with cytokeratin AE1/AE3 immunostaining.
    Weinbreck N; Marie B; Bressenot A; Montagne K; Joud A; Baumann C; Klein O; Vignaud JM
    Am J Surg Pathol; 2008 Jul; 32(7):1051-9. PubMed ID: 18496143
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Useful immunohistochemical markers in differentiating hemangioblastoma versus metastatic renal cell carcinoma.
    Rivera AL; Takei H; Zhai J; Shen SS; Ro JY; Powell SZ
    Neuropathology; 2010 Dec; 30(6):580-5. PubMed ID: 20374497
    [TBL] [Abstract][Full Text] [Related]  

  • 3. PAX2(-)/PAX8(-)/inhibin A(+) immunoprofile in hemangioblastoma: A helpful combination in the differential diagnosis with metastatic clear cell renal cell carcinoma to the central nervous system.
    Carney EM; Banerjee P; Ellis CL; Albadine R; Sharma R; Chaux AM; Burger PC; Netto GJ
    Am J Surg Pathol; 2011 Feb; 35(2):262-7. PubMed ID: 21263247
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expression of brachyury in hemangioblastoma: potential use in differential diagnosis.
    Barresi V; Vitarelli E; Branca G; Antonelli M; Giangaspero F; Barresi G
    Am J Surg Pathol; 2012 Jul; 36(7):1052-7. PubMed ID: 22446946
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunophenotypic comparison of salivary gland oncocytoma and metastatic renal cell carcinoma.
    Ozolek JA; Bastacky SI; Myers EN; Hunt JL
    Laryngoscope; 2005 Jun; 115(6):1097-100. PubMed ID: 15933529
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Image analysis of proliferating cell nuclear antigen expression and immunohistochemical profiles in renal cell carcinoma associated with acquired cystic kidney disease: comparison with classic renal cell carcinoma.
    Khurana KK; Truong LD; Verani RR
    Mod Pathol; 1998 Apr; 11(4):339-46. PubMed ID: 9578084
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The distinction of clear cell carcinoma of the female genital tract, clear cell renal cell carcinoma, and translocation-associated renal cell carcinoma: an immunohistochemical study using tissue microarray.
    He H; Zhou GX; Zhou M; Chen L
    Int J Gynecol Pathol; 2011 Sep; 30(5):425-30. PubMed ID: 21804394
    [TBL] [Abstract][Full Text] [Related]  

  • 8. D2-40 is a sensitive and specific marker in differentiating primary adrenal cortical tumours from both metastatic clear cell renal cell carcinoma and phaeochromocytoma.
    Browning L; Bailey D; Parker A
    J Clin Pathol; 2008 Mar; 61(3):293-6. PubMed ID: 17660332
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The diagnostic value of cytokeratins expression in the renal parenchyma tumors.
    Alexa A; Baderca F; Lighezan R; Izvernariu D; Raica M
    Rom J Morphol Embryol; 2010; 51(1):27-35. PubMed ID: 20191116
    [TBL] [Abstract][Full Text] [Related]  

  • 10. GLUT1 immunoreaction patterns reliably distinguish hemangioblastoma from metastatic renal cell carcinoma.
    North PE; Mizeracki A; Mihm MC; Mrak RE
    Clin Neuropathol; 2000; 19(3):131-7. PubMed ID: 14606586
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A panel of immunohistochemical stains assists in the distinction between ovarian and renal clear cell carcinoma.
    Cameron RI; Ashe P; O'Rourke DM; Foster H; McCluggage WG
    Int J Gynecol Pathol; 2003 Jul; 22(3):272-6. PubMed ID: 12819395
    [TBL] [Abstract][Full Text] [Related]  

  • 12. OCT4 is superior to CD30 in the diagnosis of metastatic embryonal carcinomas after chemotherapy.
    Sung MT; Jones TD; Beck SD; Foster RS; Cheng L
    Hum Pathol; 2006 Jun; 37(6):662-7. PubMed ID: 16733205
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparative analysis of alternative and traditional immunohistochemical markers for the distinction of ovarian sertoli cell tumor from endometrioid tumors and carcinoid tumor: A study of 160 cases.
    Zhao C; Bratthauer GL; Barner R; Vang R
    Am J Surg Pathol; 2007 Feb; 31(2):255-66. PubMed ID: 17255771
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparative immunohistochemical profile of hepatocellular carcinoma, cholangiocarcinoma, and metastatic adenocarcinoma.
    Lau SK; Prakash S; Geller SA; Alsabeh R
    Hum Pathol; 2002 Dec; 33(12):1175-81. PubMed ID: 12514785
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Detection of residual tumor cells in bladder biopsy specimens: pitfalls in the interpretation of cytokeratin stains.
    Tamas EF; Epstein JI
    Am J Surg Pathol; 2007 Mar; 31(3):390-7. PubMed ID: 17325480
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Utility of a comprehensive immunohistochemical panel in the differential diagnosis of spindle cell lesions of the urinary bladder.
    Westfall DE; Folpe AL; Paner GP; Oliva E; Goldstein L; Alsabeh R; Gown AM; Amin MB
    Am J Surg Pathol; 2009 Jan; 33(1):99-105. PubMed ID: 18941404
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Renal cell carcinoma marker reliably discriminates central nervous system haemangioblastoma from brain metastases of renal cell carcinoma.
    Ingold B; Wild PJ; Nocito A; Amin MB; Storz M; Heppner FL; Moch H
    Histopathology; 2008 May; 52(6):674-81. PubMed ID: 18393979
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Wilms tumor 1/cytokeratin dual-color immunostaining reveals distinctive staining patterns in metastatic melanoma, metastatic carcinoma, and mesothelial cells in pleural fluids: an effective first-line test for the workup of malignant effusions.
    Conner JR; Cibas ES; Hornick JL; Qian X
    Cancer Cytopathol; 2014 Aug; 122(8):586-95. PubMed ID: 25044880
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Metastatic renal cell carcinoma to the oral cavity and clear cell mucoepidermoid carcinoma: comparative clinicopathologic and immunohistochemical study.
    Pires FR; Azevedo RS; Ficarra G; Cardoso AS; Carlos R; Kowalski LP; de Almeida OP
    Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2010 Apr; 109(4):e22-7. PubMed ID: 20303042
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hormone receptor immunoreactivity in hemangioblastomas and clear cell renal cell carcinomas.
    Brown DF; Dababo MA; Hladik CL; Eagan KP; White CL; Rushing EJ
    Mod Pathol; 1998 Jan; 11(1):55-9. PubMed ID: 9556423
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.